+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Cochrane review on 'Statins for the treatment of dementia'



Cochrane review on 'Statins for the treatment of dementia'



International Journal of Geriatric Psychiatry 28(2): 119-126



This review aimed to assess the clinical efficacy and tolerability of statins in the treatment of dementia. We searched the Specialized Register of the Cochrane Dementia and Cognitive Improvement Group, The Cochrane Library, MEDLINE, EMBASE, PsycINFO, CINAHL and LILACS, as well as many trials registries and grey literature sources (27 October 2008). Double-blind, randomized controlled trials of statins given for at least 6 months in people with a diagnosis of dementia were included. Two independent authors extracted and assessed data independently against the inclusion criteria. Data were pooled where appropriate and entered into a meta-analysis. Three studies were identified (748 participants, age range 50-90 years). All patients had a diagnosis of probable or possible Alzheimer's disease according to standard criteria, and most patients were established on a cholinesterase inhibitor. Change in Alzheimer's Disease Assessment Scale cognitive subscale from baseline was a primary outcome in three studies; when data were pooled, statins did not provide any beneficial effect in this cognitive measure (mean difference -1.12; 95% confidence interval -3.99, 1.75; p = 0.44). All studies provided a change in Mini-Mental State Examination from baseline; there was no significant benefit from statins in this cognitive measure when the data were pooled (mean difference -1.53; 95% confidence interval -3.28; 0.21, p = 0.08). There were no studies identified assessing the role of statins in treatment of vascular dementia. There was no evidence that statins were detrimental to cognition. There is insufficient evidence to recommend statins for the treatment of dementia.

(PDF emailed within 0-6 h: $19.90)

Accession: 036372986

Download citation: RISBibTeXText

PMID: 22473869

DOI: 10.1002/gps.3797


Related references

Analysis of the Cochrane Review: Omega-3 Fatty Acids for the Treatment of Dementia. Cochrane Database Syst Rev. 2016;4:CD009002. Acta Medica Portuguesa 30(10): 671-674, 2018

Omega 3 fatty acids for the treatment of dementia: a Cochrane review summary. International Journal of Nursing Studies 67: 83-84, 2016

Ginkgo biloba compared with cholinesterase inhibitors in the treatment of dementia: a review based on meta-analyses by the cochrane collaboration. Dementia and Geriatric Cognitive Disorders 18(2): 217-226, 2004

Cochrane review questions evidence for statins for primary prevention in low risk groups. BMJ 342: D480, 2011

Systematic review of statins for the prevention of vascular dementia or dementia. Geriatrics and Gerontology International 10(2): 199-208, 2010

P.5.b.001 Cochrane review of valproate preparations for agitation in dementia. European Neuropsychopharmacology 25: S581-S582, 2015

Simulated presence therapy for dementia: A Cochrane review summary. International Journal of Nursing Studies 85: 138-139, 2018

A Cochrane review on brain [¹⁸F]FDG PET in dementia: limitations and future perspectives. European Journal of Nuclear Medicine and Molecular Imaging 42(10): 1487-1491, 2016

Statins and vascular dementia: a review. Journal of Alzheimer's Disease 42 Suppl 3: S315-S320, 2015

Cochrane Review Brief: Mini-Cog for the Diagnosis of Alzheimer’s Disease Dementia and Other Dementias within a Community Setting. Online Journal of Issues in Nursing 21(1): 12, 2016

The effects of statins on prevention of stroke and dementia: a review. Journal of Cardiopulmonary Rehabilitation and Prevention 32(5): 240-249, 2013

Treatment of dementia and cognitive impairment: what can we learn from the Cochrane Library. Journal of the Neurological Sciences 283(1-2): 207-210, 2009

Reminiscence therapy for dementia: an abridged Cochrane systematic review of the evidence from randomized controlled trials. Expert Review of Neurotherapeutics 18(9): 715-727, 2018

Enteral tube feeding in older people with advanced dementia: findings from a Cochrane systematic review. International Journal of Palliative Nursing 15(8): 396-404, 2009

Statins for the treatment of dementia. Cochrane Database of Systematic Reviews 2015(7): Cd007514, 2015